Dr. Patrick McNeillie
Founder & Chief Information Officer
Dr Patrick McNeillie NeuralFrame Co-Founder and Chief Technology Officer leads the systems training for natural language processing in artificial intelligence at NeuralFrame. Dr. McNeillie has been active in basic science and clinical oncology research for more than 10 years with over 30 peer-viewed publications. He has spoken extensively about innovations within cancer treatment and in 2012, he won the Pillsbury Award for Outstanding Oral Presentation in Clinical Medicine.
In 2013, Dr. McNeillie took a position at IBM as a Post-Doctoral Research Fellow. During that time he worked alongside IBM computer scientists in applying the cognitive technologies of IBM Watson to healthcare. He decided to extend his time at IBM and was promoted to Chief Physician Researcher of the Medical Sieve Grand Challenge where he was responsible for developing technology for medical image analytics. In 2015 he transitioned from IBM Research to Watson Genomic Analytics to assist in the development of technology to identify genetic alterations driving cancer and the therapies that target these dysfunctional proteins.
Committed to his unique vision of using artificial intelligence to improve cancer care, Dr. McNeillie left IBM in 2017 to found NeuralFrame.
Dr. McNeillie holds a Bachelor of Applied Science (B.A.Sc) in Biology from the University of North Carolina at Chapel Hill, and a Doctor of Medicine (M.D.) from the University of North Carolina at Chapel Hill School of Medicine.